Every Form 4 that Intuitive Surgical Inc. (ISRG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ISRG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ISRG filings page.
Intuitive Surgical (ISRG) EVP Mark Brosius reported selling 61 shares of Common Stock on each of October 26, October 27 and October 28, 2026. The reported prices were $451.75, $451.63 and $441.60 per share, respectively. Each sale took place under a Trading Plan that complies with SEC Rule 10b5-1 and expires February 14, 2027.
Craig H. Barratt, an Intuitive Surgical director, exercised 1,150 non-qualified stock options at $90.4944 per share on October 23, 2026, acquiring 1,150 common shares, and sold 1,150 common shares at $443.80 per share that day. The transactions were under a Rule 10b5-1 trading plan expiring March 15, 2027. Afterward, 3,485 options remained; a separate holding entry lists 27,948 shares held indirectly by a trust.
Intuitive Surgical Inc. (ISRG) VP Corporate Controller Fredrik Widman exercised 11 non-qualified stock options on October 23, 2026, acquiring 4,047 common shares, and sold 4,047 common shares at a weighted-average price of $453.2059 per share. The sale executions ranged from $444.44 to $458.02 per share. The transactions were reported under a Rule 10b5-1 trading plan expiring September 15, 2027.
Intuitive Surgical Inc. officer Patricia L. Wadors sold 1,078 shares of common stock at $443.80 per share on October 23, 2026. Her reported direct common-stock holdings after the sale were 0 shares. The sale was made under a Rule 10b5-1 Trading Plan.
Intuitive Surgical (ISRG) director Gary S. Guthart reported the sale of 20,095 shares held indirectly by a Trust on October 23, 2026, at a weighted average sale price of $451.6117 per share. The reported post-sale position held through a Trust was 1,204,530 shares. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2027. The reported indirect holdings also included 26,247 shares in a Trust FBO Daughter and 26,247 shares in a Trust FBO Son.
Patricia L. Wadors, Intuitive Surgical’s SVP and Chief Human Resources Officer, had 2,140 restricted stock units convert into 2,140 common shares on October 10, 2026. Of those shares, 1,062 were withheld to cover tax-withholding obligations at $423.96 per share; net shares were deposited into the holder’s account. Her reported post-transaction RSU balance was 4,279.
Intuitive Surgical (ISRG) executive vice president Gary Loeb reported conversion of 2,612 restricted stock units into 2,612 common shares on October 10, 2026. 1,296 shares were withheld to cover tax withholding obligations at $423.96 per share, and the net shares were deposited into the holder’s account. The RSUs vest 25% per year over four years, beginning on the grant’s first anniversary; no Rule 10b5-1 plan is reported.
INTUITIVE SURGICAL INC (ISRG) executive Fredrik Widman, VP Corporate Controller, reported an exercise-and-sell transaction on September 15, 2026 under a Rule 10b5-1 trading plan. He exercised options for 546 and 543 shares of common stock and sold the corresponding 1,089 shares on the same day.
INTUITIVE SURGICAL INC (ISRG) executive Mark Brosius, EVP & Chief Manufacturing and Supply Chain, reported selling a total of 48 shares of common stock in open market or private transactions on September 10 and 11, 2026, under a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.
INTUITIVE SURGICAL INC (ISRG) reported that executive vice president and chief manufacturing and supply chain officer Mark Brosius sold a total of 69 shares of common stock in two transactions. On September 8, 2026 he sold 46 shares at $361.23 per share, and on September 9, 2026 he sold 23 shares at $350.20 per share. Both sales were made in open market or private transactions pursuant to a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.
INTUITIVE SURGICAL INC (ISRG) reported that executive vice president and Chief Manufacturing and Supply Chain officer Mark Brosius sold a total of 154 shares of common stock in two open-market transactions on August 20 and 21, 2026, at prices of $396.37 and $375.57 per share. Both sales were made pursuant to a pre-arranged Trading Plan that complies with SEC Rule 10b5-1 and is disclosed as expiring on February 14, 2027.
INTUITIVE SURGICAL INC (ISRG) executive Mark Brosius, EVP & Chief Manufacturing and Supply Chain, reported three small open-market sales of common stock, each for 77 shares, on August 17, 18, and 19, 2026, at per-share prices of $390.67, $394.00, and $394.26, respectively. All transactions were executed under a Rule 10b5-1 trading plan that the company states complies with SEC requirements and expires on February 14, 2027.
INTUITIVE SURGICAL INC director Gary S. Guthart reported an indirect sale of common stock for a trust on August 11, 2026. The trust sold 10,000 shares of common stock at a price of $400.00 per share in an open-market or private transaction. After this sale, the trust held 1,245,679 shares indirectly. Separate indirect holdings of 15,720 shares each are reported in trusts for a daughter and a son. The sale was executed under a Rule 10b5-1 trading plan expiring on June 15, 2027.
Intuitive Surgical Inc. director Amy L. Ladd reported two open-market sales of Intuitive Surgical common stock. On August 10, 2026, she sold 400 shares at $379.00 per share, and on August 11, 2026, she sold 72 shares at $393.10 per share. Both transactions were executed under a Rule 10b5-1 trading plan that expires on May 15, 2027.
Intuitive Surgical Inc. executive Gary Loeb, EVP & Chief Legal and Compliance Officer, reported selling 400 shares of common stock on August 10, 2026 at $379.00 per share. Following this sale, he directly holds 5,320 shares. The sale was executed under a Rule 10b5-1 Trading Plan that expires on January 29, 2027.
Intuitive Surgical executive Mark Brosius, EVP & Chief Mfg and Supply Cha, reported selling a total of 56 shares of common stock in two open-market or private transactions: 28 shares at 351.0000 per share on July 31, 2026 and 28 shares at 346.8300 per share on July 30, 2026. The sales took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.
INTUITIVE SURGICAL INC executive Brosius Mark, EVP & Chief Mfg and Supply Cha, reported selling a total of 84 shares of Common Stock in three open-market transactions. He sold 28 shares on each of July 27, 28, and 29, 2026 at prices between $344.00 and $365.58 per share.
All reported sales were made pursuant to a pre-arranged Trading Plan that complies with SEC Rule 10b5-1, as noted in the footnote, and this plan is stated to expire on February 14, 2027.
INTUITIVE SURGICAL INC Chief Executive Officer David J. Rosa reported routine equity compensation activity. On July 10, 2026, 1,910 Restricted Stock Units vested and converted into common stock, with 947 shares withheld at $411.55 per share to cover statutory taxes. Following these transactions, Rosa holds 246,856 common shares directly and 5,730 RSUs.
Intuitive Surgical executive Mark Brosius, EVP & Chief Manufacturing and Supply Chain, reported small open-market sales of company common stock. He sold 25 shares at $414.13 on June 12, 2026 and 23 shares at $412.16 on June 11, 2026, totaling 48 shares. After these transactions, he directly holds 1,406 shares of Intuitive Surgical common stock. The trades were executed under a pre-arranged Rule 10b5-1 trading plan that is stated to expire on February 14, 2027, indicating the timing was set in advance.
Intuitive Surgical EVP & Chief Manufacturing and Supply Chain officer Mark Brosius reported small open-market sales of company Common Stock. Across three days, he sold a total of 69 shares at prices between $420.12 and $424.14 per share.
After these transactions, Brosius directly holds 1,454 shares of Intuitive Surgical Common Stock. The filing notes that the trades were executed under a Trading Plan that complies with SEC Rule 10b5-1 and is scheduled to expire on February 14, 2027.
INTUITIVE SURGICAL INC executive Gary Loeb reported an open-market sale of 400 shares of Common Stock. The shares were sold at a price of $424.14 per share. After this transaction, he directly holds 5,720 shares. The sale was executed under a pre-arranged Trading Plan that complies with SEC Rule 10b5-1 and is scheduled to expire on January 29, 2027, indicating the timing was set in advance rather than being a discretionary trade.
INTUITIVE SURGICAL INC CEO David J. Rosa reported routine equity compensation activity involving restricted stock units (RSUs). On June 10, 2026, 1,358 RSUs granted on June 10, 2023 vested and converted into the same number of common shares on a one-for-one basis. To satisfy statutory tax withholding requirements, 674 of those shares were disposed of at a reference price of $426.61 per share, with the remaining net shares deposited into the holder’s account. The RSU award vests 25% per year over four years, subject to continued service. Following these transactions, Rosa directly holds 245,893 shares of Intuitive Surgical common stock.
Intuitive Surgical senior executive Iman Jeddi exercised stock options and sold shares in a routine, pre-planned transaction. On the same day, he exercised 5,625 non-qualified stock options at $76.9989 per share and sold 5,625 common shares at $420.55 per share under a Rule 10b5-1 trading plan. After these transactions, he holds 6,463 common shares directly and 26,649 common shares indirectly through a trust.
Intuitive Surgical executive Mark Brosius reported small open-market sales of company stock under a pre-set trading plan. The EVP & Chief Manufacturing and Supply Chain sold 18 shares of Common Stock on May 21, 2026 at $446.04 per share and another 18 shares on May 22, 2026 at $439.80 per share. These transactions were carried out pursuant to a Rule 10b5-1 Trading Plan that expires on February 14, 2027. After these sales, Brosius directly holds 1,523 shares of Intuitive Surgical Common Stock.
Intuitive Surgical EVP & Chief Manufacturing and Supply Chain officer Mark Brosius reported small open-market sales of company common stock. Over three days, he sold 18 shares on each of May 18, May 19, and May 20, 2026 at prices of $422.47, $440.70, and $440.38 per share.
After these sales totaling 54 shares, Brosius directly holds 1,559 shares of Intuitive Surgical common stock. The filing notes that the transactions were executed under a pre-arranged Trading Plan that complies with SEC Rule 10b5-1 and runs through February 14, 2027, indicating they were scheduled in advance rather than discretionary trades.
INTUITIVE SURGICAL INC executive Gary Loeb, EVP & Chief Legal and Compliance, reported an open-market sale of 400 shares of Common Stock at $446.95 per share. The transaction was executed under a Rule 10b5-1 trading plan that expires on January 29, 2027. Following this sale, he directly holds 6,120 shares of the company’s stock.
GUTHART GARY S reported acquisition or exercise transactions in this Form 4 filing.
Intuitive Surgical Inc. director Gary S. Guthart received a grant of 554 restricted stock units tied to the company’s common stock. These RSUs were awarded at no cash cost per unit and represent a stock-based compensation award rather than an open-market purchase.
According to the terms, 100% of the RSUs will vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to his continued service. After this grant, the reported holding for this RSU award is 554 units.
INTUITIVE SURGICAL INC director Monica P. Reed reported routine equity compensation activity. On April 30, 2026, she exercised 531 shares of restricted stock units into the same number of common shares, bringing her direct common stock holdings to 2,876 shares.
On the same date, she received a new grant of 554 restricted stock units. According to the disclosure, 100% of these RSUs will vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to her continued service.
INTUITIVE SURGICAL INC director Jami K. Nachtsheim reported routine equity compensation activity, with only share acquisitions and no sales. On April 30, 2026, she exercised 531 Restricted Stock Units into Common Stock, bringing her direct Common Stock holdings to 6,902 shares.
On the same date she also received a new grant of 554 Restricted Stock Units tied to Common Stock. According to the filing, 100% of these RSUs will vest on the earlier of one year from grant or the next Annual Meeting of Stockholders, as long as she continues in service.
INTUITIVE SURGICAL INC director Leonard Keith R reported equity compensation activity involving Restricted Stock Units (RSUs) and common stock. He exercised 531 RSUs into 531 shares of common stock on April 30, 2026, and did not report any same-day sales.
Following the exercise, he held 901 shares of common stock directly. On the same date, he also received a grant of 554 RSUs tied to common stock. According to the disclosure, 100% of these RSUs will vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to his continued service.
INTUITIVE SURGICAL INC director Amy L. Ladd reported compensation-related equity activity involving company stock. On April 30, 2026, she exercised 531 Restricted Stock Units, which converted into 531 shares of Common Stock, leaving her with 651 Common shares held directly after the transaction.
On the same date, she also received a new grant of 554 Restricted Stock Units, each representing a right to receive one share of Common Stock. According to the filing, 100% of these RSUs vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to her continued service.
Intuitive Surgical director Sreelakshmi Kolli reported equity compensation activity involving Restricted Stock Units (RSUs) and common stock. She exercised 531 RSUs into 531 shares of common stock and, after this transaction, directly held 1,510 shares of common stock.
She was also granted 554 new RSUs linked to common stock, which represent a new award of derivative securities. According to the disclosure, 100% of these RSUs will vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to her continued service.
Intuitive Surgical director Amal M. Johnson exercised 531 Restricted Stock Units into 531 shares of Common Stock. The RSUs vested based on service, with 100% vesting on the earlier of one year from grant or the next Annual Meeting of Stockholders. After this conversion, Johnson directly holds 13,545 shares of Common Stock, and the reported RSU award has been fully converted with no remaining balance shown.
INTUITIVE SURGICAL INC director Lewis Chew reported routine equity compensation changes. On April 30, 2026, he exercised 531 shares of restricted stock units into an equal number of common shares, bringing his direct common stock holdings to 1,314 shares after the transaction.
On the same date, he also received a new grant of 554 restricted stock units, each representing one share of common stock. According to the terms, 100% of these RSUs will vest on the earlier of one year from grant or the next Annual Meeting of Stockholders, assuming he continues in service.
INTUITIVE SURGICAL INC director Joseph C. Beery reported routine equity compensation activity. On April 30, 2026, he exercised 531 shares of Restricted Stock Units into Common Stock, bringing his direct Common Stock holdings to 3,641 shares after the transactions.
On the same date, he received a new grant of 554 Restricted Stock Units. According to the footnote, 100% of these RSUs will vest on the earlier of one year from the grant date or the next Annual Meeting of Stockholders, subject to his continued service. The filing shows only acquisitions and no open‑market buying or selling.
INTUITIVE SURGICAL INC director Craig H. Barratt reported equity compensation activity involving common stock and restricted stock units. On April 30, 2026, a trust associated with him acquired 750 shares of common stock through the exercise of restricted stock units, bringing its indirect holdings to 27,948 shares.
The same day, Barratt received a new grant of 643 restricted stock units, each representing one share of common stock. According to the disclosure, 100% of these RSUs vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to his continued service.
INTUITIVE SURGICAL INC director Amy L. Ladd reported open-market sales of company Common Stock over two days. She sold 500 shares at $473.46 per share on April 28, 2026, and 119 shares at $463.50 per share on April 29, 2026. After these transactions, she directly holds 120 shares. The filing notes that the activity occurred under a Trading Plan that complies with SEC Rule 10b5-1 and runs through January 29, 2027, indicating the sales were pre-scheduled rather than discretionary.
INTUITIVE SURGICAL INC EVP & Chief Medical Officer Myriam Curet exercised options and sold shares in a coordinated transaction. She exercised a non-qualified stock option for 105 shares of common stock at an exercise price of $229.39 per share, then sold the 105 shares of common stock on the same day at an average price of $493.95 per share. The sale was carried out under a pre-arranged Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026, indicating the timing was pre-scheduled. After these transactions, she directly holds no common shares but indirectly holds 409 shares by trust and continues to hold 1,152 option shares, so the sale represents a relatively small portion of her overall equity exposure to the company.
Intuitive Surgical SVP Mark Brosius reported selling 1,293 shares of Common Stock in open-market transactions. He sold 648 shares at $490.19 per share on March 6, 2026, and 645 shares at $485.01 per share on March 9, 2026. After these sales, he directly holds 1,613 shares. The transactions were executed under a pre-arranged Trading Plan that complies with SEC Rule 10b5-1 and runs through February 14, 2027, indicating these sales were scheduled in advance rather than timed discretionarily.
Intuitive Surgical senior executive Mark Brosius reported open-market sales of company common stock. As SVP and Chief Manufacturing and Supply Chain Officer, he sold a total of 3,658 shares across three transactions on March 3, 4, and 5, 2026.
The sales were executed at weighted-average prices of about $488.10, $498.6804, and $495.20 per share, with detailed price ranges provided in the footnotes. After these transactions, he directly held 2,906 shares of Intuitive Surgical common stock. All sales took place under a Trading Plan that complies with SEC Rule 10b5‑1 and expires on February 14, 2027.
Intuitive Surgical VP Corporate Controller Fredrik Widman reported planned share sales and RSU vesting activity. He sold 249 shares of common stock on February 27, 2026 at $499.71 per share, and 118 shares on March 3, 2026 at $487.18 per share in open-market transactions under a Rule 10b5-1 trading plan that runs through May 21, 2026.
These sales followed the vesting of 468 restricted stock units on February 28, 2026, which converted into the same number of common shares. To cover statutory tax withholding on the vesting, 233 shares of common stock were disposed of at $503.51 per share. After these transactions, Widman directly held just over one thousand common shares.
Intuitive Surgical EVP & Chief Medical Officer Myriam Curet reported net insider sales of common stock through a trust. A trust associated with her sold 4,728 shares on March 3, 2026 at an average price of $487.18 per share, leaving 409 indirectly owned shares.
On March 2, 2026, a non-qualified stock option for 125 shares was exercised and converted into common stock at an exercise price of $208.90 per share, and those 125 shares were then sold the same day at $492.59 per share. The option position now shows zero shares remaining. The transactions were carried out under a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
Intuitive Surgical executive Iman Jeddi, SVP & GM da Vinci Platforms, reported the vesting and settlement of equity awards. Performance stock units granted in 2023 and restricted stock units granted in 2022 were converted into common shares, with portions of the resulting stock (311 and 4,155 shares at $503.51) withheld to cover tax obligations rather than sold in the open market. Following these transactions, Jeddi holds common stock directly and indirectly through a trust.
Intuitive Surgical director Gary S. Guthart reported multiple equity award transactions in company stock. On February 28, 2026, he exercised 26,334 performance stock units and 2,506 restricted stock units, which converted into an equal number of common shares at no exercise price.
To satisfy statutory tax withholding on these settlements, 1,243 shares and 13,059 shares of common stock were disposed of at $503.51 per share, described as share withholding rather than open-market selling. Following these transactions, Guthart continued to hold common stock directly and also indirectly through several trusts for family members.
INTUITIVE SURGICAL INC executive Jamie Samath, EVP & CFO & Enterprise Technol, reported equity award activity involving performance and restricted stock units. On February 28, 2026, 10,773 performance stock units and 752 restricted stock units were converted into common stock following achievement of performance criteria and scheduled vesting. To satisfy statutory tax withholding obligations tied to these vestings, 373 and 5,343 common shares, respectively, were withheld at a price of $503.51 per share, with the remaining net shares delivered into the holder’s account.
Intuitive Surgical executive Gary Loeb exercised performance stock units and had shares withheld for taxes. On February 28, 2026, he converted 3,148 performance stock units granted on February 28, 2023 into 3,148 shares of common stock at $0.0000 per share, following achievement of required performance criteria.
The performance stock units vest on February 28, 2026, the third anniversary of the grant date, subject to his continuous service. In connection with this settlement, 1,562 common shares were withheld at $503.5100 per share to cover applicable taxes, leaving him with 6,520 directly owned common shares.
Intuitive Surgical EVP Henry L. Charlton reported multiple equity award settlements in the form of stock unit conversions and tax withholdings. On February 28, 2026, 10,773 performance stock units and 752 restricted stock units converted into common stock at no exercise price. A total of 335 and 4,800 common shares were withheld at $503.51 per share to cover statutory tax obligations related to these vestings. RSUs vest 25% per year over four years, while the reported PSUs vest on February 28, 2026 after performance criteria were achieved. Following these transactions, Charlton directly owned 11,610 shares of common stock.
Intuitive Surgical CEO David J. Rosa reported multiple equity transactions on February 28, 2026 tied to vesting of performance and restricted stock units. He exercised or converted derivative awards into common stock, including 14,363 and 9,052 performance stock units from 2023 grants and 1,503 restricted stock units, each on a one-for-one basis into common shares.
To satisfy statutory tax withholding on these settlements, the company withheld shares classified as dispositions under code F, including 7,122, 4,489, and 746 common shares at a price of $503.51 per share. After these exercises and tax-withholding dispositions, Rosa directly owned 245,209 shares of Intuitive Surgical common stock.
Intuitive Surgical SVP and Chief Manufacturing and Supply Chain Officer Mark Brosius reported equity vesting and related tax withholdings. On February 28, 2026, 8,378 performance stock units granted on February 28, 2023 and 877 restricted stock units granted on February 28, 2022 converted into common stock.
In connection with these settlements, 435 and 4,155 shares of common stock were withheld at a price of $503.51 per share to cover tax liabilities and exercise costs. After these transactions, Brosius directly owned 6,564 shares of Intuitive Surgical common stock.
Intuitive Surgical EVP & Chief Medical Officer Myriam Curet reported multiple equity award transactions involving performance stock units (PSUs), restricted stock units (RSUs), and common stock. PSUs initially granted on February 28, 2023 had their performance criteria certified, and the resulting PSUs vested on February 28, 2026, converting into common shares.
On the same date, RSUs also vested and converted one-for-one into common stock. Some of the newly delivered shares were withheld to cover statutory tax obligations related to the PSU and RSU settlements, using shares valued at about $503.51 per share. In a separate move on February 27, 2026, a trust associated with Curet sold 2,345 shares of Intuitive Surgical common stock at an average price of $499.71 per share under a pre-arranged Rule 10b5-1 trading plan that expires on July 29, 2026.